Skip to main content
All lobbying filings

AKIN GUMP STRAUSS HAUER & FELD

Lobbying for BIOTECHNOLOGY INNOVATION ORGANIZATION

 Filing 3rd Quarter - Report
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $60,000.00 income · posted Oct 20, 2025

Official filing document

 Bills named in this filing 2
  • HR 1262
    Mikaela Naylon Give Kids a Chance Act
  • S 932
    Give Kids a Chance Act of 2025
 Lobbying activity 2
Health Issues

Issues related to Rare Pediatric Disease Priority Review Voucher Program reauthorization; Issues related to H.R. 1262/S. 932 - Give Kids a Chance Act of 2025.

Medicare/Medicaid

Issues related to the One Big Beautiful Bill Act (P.L. 119-21) Section 44301, expanding and clarifying the exclusion for orphan drugs under the Drug Price Negotiation Program.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem